After a ten-year hiatus, Amsterdam is once again set the stage for Europe’s largest medical conference: the European Society of Cardiology (ESC).
ESC Congress 2023, will bring together cardiologists and researchers who will discuss, among other things, creating the future of cardiology. From 25-28 August, RAI Amsterdam will host over 23,000 onsite attendees and several thousand online.
The ESC Congress is also the largest conference covering cardiovascular issues in the world and this year’s conference spotlight will be on heart failure. Many of the problems cardiovascular professionals deal with are either the cause or complications of heart failure, including coronary artery disease, valvular problems, stroke, arrhythmias and sudden death.
Heart failure is relevant to all areas of cardiology and beyond, including obesity, diabetes and chronic kidney disease, which is why it makes it such a relevant subject for ESC.
The Amsterdam area is an ideal location to host the event not least because so many world-leading life sciences companies are based there, as well as four world leading research centres.
Dennis Speet, director Amsterdam Convention Bureau, says: “We are proud to welcome the ESC’s scientists, clinicians, nurses and allied professionals working in all fields of cardiology. These specialists contribute to the knowledge in the Amsterdam Metropole and the Netherlands, overcoming the challenges of the future.”
RAI Amsterdam is also ready to receive the 23,000 cardiology professionals and Maurits van der Sluis, COO at the venue, says: “This is such an important event for the Life Sciences & Health industry, connecting so many professionals that face the enormous challenge of tackling cardiovascular disease. We hope that the many connections and sharing of information breaks new ground for the industry. All the ingredients for a successful cardiology conference are in place. We are ready to make it happen.”
Leading scientists will give more than 800 scientific sessions, plenary lectures and seminars on the latest research and clinical trials during the ESC Congress 2023. The 3,752 abstracts accepted from 90 countries will cover more than 100 cardiovascular issues.